RetiSpec is a medical imaging company developing a tool for the early detection of Alzheimer’s disease biomarkers in the eye.
Our goal is to enable widespread early detection of Alzheimer’s disease with accessible and scalable screening.
Adam Gribble, PhD
Adam has 7 years of hands-on experience in both fundamental and applied optics research, including bio-imaging, spectral analysis, and development of optical instrumentation
Catherine Bornbaum, PhD, MBA
Head of Clinical Operations & Partnerships
Catherine is a health scientist and MBA with 10+ years of experience leading large scale health research operations. In 2019, she was named one of the 100 Best & Brightest Executive MBAs globally by Poets & Quants.
Eliav Shaked, M.Sc
Eliav is an experienced biomedical engineer having led several medical products from ideation to launch, and a recent graduate of Singularity University’s flagship GSP program (NASA/Google)
Jared Westreich, M.Sc
Jared is an experienced data scientist with a background in medical biophysics and expertise in machine learning techniques
Roy Kirshon, MBA
Roy is a biomedical engineer, and an MBA. With 10 years of experience building new initiatives and working with ventures, Roy has lead new technologies and early stage startups to market
Michael Wood, PhD
Michael is an experienced R&D director with expertise in medical biophysics. He has managed large scale programs as well as commercialization over the past 8 years
Maïlis Bietenhader, PhD
Ocular Imaging Specialist
Mailis is an expert in ophthalmic imaging. After a PhD in Molecular Biology and a successful post-doctoral fellowship at the University of Toronto, she combines her background in research with 6 years of clinical experience